• University of Southern California
    $120,000 through December, 2019

    to study the potential of angiotensin 1-7 to promote oligodendrocyte progenitor cell remyelination.

    Multiple Sclerosis USA Awarded: May, 2017
  • Johns Hopkins University
    $45,938 through June, 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Vanderbilt University Medical Center
    $120,000 through June, 2020

    to apply advanced imaging to the study of the cervical spinal cord in patients with MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Baylor College of Medicine
    $120,000 through June, 2019

    to study how targeting the Wnt receptor complex may increase myelin repair in MS patients.

    Multiple Sclerosis USA Awarded: May, 2017
  • Washington University
    $120,000 through June, 2020

    to identify biomarkers in cerebrospinal fluid that may predict MS disease progression and responses to therapy.

    Multiple Sclerosis USA Awarded: May, 2017
  • The Massachusetts General Hospital
    $120,000 through June, 2020

    to develop imaging markers of axonal damage and myelin integrity in MS patients using ultra-high gradient MRI techniques.

    Multiple Sclerosis USA Awarded: May, 2017
  • Johns Hopkins University
    $585,000 through June, 2023

    to study how to reduce chronic inflammation in MS patients.

    Multiple Sclerosis USA Awarded: May, 2017
  • Trustees of the University of Pennsylvania
    $552,710 through April, 2022

    to use advanced imaging techniques to study what role astrocytes cells in the cortex may play in promoting remyelination in MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Icahn School of Medicine at Mount Sinai
    $117,584 through June, 2021

    to study astrocytic regulation of immune cell activity during central nervous system inflammation.

    Multiple Sclerosis USA Awarded: May, 2017
  • Johns Hopkins University
    $535,000 through June, 2022

    to study signaling pathways that lead to free radical damage in MS patients.

    Multiple Sclerosis USA Awarded: May, 2017